TNSN08171A1 - Pharmaceutical composition comprising at least one anticancer drug and at least one polymer - Google Patents

Pharmaceutical composition comprising at least one anticancer drug and at least one polymer

Info

Publication number
TNSN08171A1
TNSN08171A1 TNP2008000171A TNSN08171A TNSN08171A1 TN SN08171 A1 TNSN08171 A1 TN SN08171A1 TN P2008000171 A TNP2008000171 A TN P2008000171A TN SN08171 A TNSN08171 A TN SN08171A TN SN08171 A1 TNSN08171 A1 TN SN08171A1
Authority
TN
Tunisia
Prior art keywords
methods
polymer
compositions
pharmaceutical composition
anticancer drug
Prior art date
Application number
TNP2008000171A
Inventor
Amarjit Singh
Sarabjit Singh
Ajay K Gupta
Mangesh M Kulkarni
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IN2006/000427 external-priority patent/WO2007069272A2/en
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of TNSN08171A1 publication Critical patent/TNSN08171A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to novel and improved compositions of anticancer drugs, preferably taxanes, such as paclitaxel and docetaxel, their derivatives or their analogues, methods of manufacturing these compositions and methods of fractionating the particles in particular size range and methods of treating cancer patients with these compositions, which provide reduced chemotherapy-induced side-effects especially reduced chemotherapy-induced- alopecia. The composition is such that there is substantially no free drug in the said composition.
TNP2008000171A 2006-07-10 2008-04-18 Pharmaceutical composition comprising at least one anticancer drug and at least one polymer TNSN08171A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1081MU2006 2006-07-10
PCT/IN2006/000427 WO2007069272A2 (en) 2005-10-21 2006-10-19 Pharmaceutical composition comprising at least one anticancer drug and at least one polymer

Publications (1)

Publication Number Publication Date
TNSN08171A1 true TNSN08171A1 (en) 2009-10-30

Family

ID=59846284

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2008000171A TNSN08171A1 (en) 2006-07-10 2008-04-18 Pharmaceutical composition comprising at least one anticancer drug and at least one polymer

Country Status (1)

Country Link
TN (1) TNSN08171A1 (en)

Similar Documents

Publication Publication Date Title
WO2007069272A3 (en) Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
NZ593343A (en) Combination cancer treatment conprising Abraxane and an inflamatory inhibitor
WO2009120697A3 (en) Method and compositions for treatment of cancer
WO2007139930A3 (en) Drug combinations with substituted diaryl ureas for the treatment of cancer
MX2009004803A (en) Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer.
EA200870219A1 (en) STABILIZED WITH VITAMIN E SUCCINAT PHARMACEUTICAL COMPOSITIONS, METHODS FOR THEIR PRODUCTION AND USE
WO2004035629A3 (en) Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
MX2009009537A (en) Nanoparticle comprising rapamycin and albumin as anticancer agent.
MX2010002179A (en) Composition.
MX2009012155A (en) A synergistic pharmaceutical combination for the treatment of cancer.
EP1988910A4 (en) Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
NZ588913A (en) Liver cancer drug
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
JP2013503174A5 (en)
WO2008105852A3 (en) Mucoadhesive nanoparticles for cancer treatment
BRPI0806863B8 (en) use of a phorbol ester in the preparation of a drug to prevent or treat an HIV infection
WO2006133707A3 (en) Anti-cancer combination treatment and kit-of-part
MX2017015879A (en) Hydroxypropyl beta-cyclodextrin compositions and methods.
EP2061456A4 (en) Compositions and methods for inhibiting cytochrome p450
BRPI0816798A2 (en) compound, pharmaceutical composition, methods for inhibiting the action of glycogen synthase kinase-3, and for treating, preventing or ameliorating a disease, use of a compound, and article of manufacture
WO2008116161A3 (en) Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states
PE20061090A1 (en) PREPARATIONS OF SUBSTITUTED TAXANS WITH CYCLOPROPYL ESTERS IN C10
UA95088C2 (en) Composition comprising at least one anticancer drug and at least one polymer and reducing chemotherapy-induced alopecia, process for the preparation thereof
EP1503748A4 (en) Drugs for mitigating taxane-induced neurotoxicity
WO2017013490A3 (en) Therapeutic combinations of orally administered paclitaxel and a p-gp inhibitor for the treatment of cancer